—m‘

Plotkin's Vaccines, 7th ed.

’˜ŽÒ : S.A.Plotkin, W.A.Orenstein, P.A.Offit, et al.(eds.)
o”ÅŽÐ : SAUNDERS
ISBN : 978-0-323-35761-6
ƒy[ƒW” : 1691pp.(600illus.)
o”Å”N : 2018”N

ÝŒÉ‹Í­

’艿58,309‰~(–{‘Ì53,990‰~ { Å)

  • E-Book
  • ¤•ià–¾
  • Žå—v–ÚŽŸ

ƒƒNƒ`ƒ“‚ÆŠ´õÇ‚Ì‹†‹É‚Ì•S‰ÈŽ–“TCƒvƒƒbƒgƒLƒ“‚̉ü’ù‘æ7”ŁDÅæ’[‚̃ƒNƒ`ƒ“‚ÆŠ´õÇ‚ÉŠÖ‚·‚é‘S‚Ä‚Ì’mŒ©‚ð–Ô—…‚µ‚Ä‚¨‚èCŠeƒƒNƒ`ƒ“‚ÌŒø”\C—¯ˆÓŽ–€C”ï—p‘ÎŒø‰Ê•ªÍ‚ƁCŠeŠ´õÇ‚Ì”÷¶•¨“I“Á’¥CŽ¡—Ö@CŠ´õ‘΍ô‚È‚Ç‚ðŽ¿‚Ì‚‚¢•¶‘̂ʼnðà‚µ‚Ä‚¢‚éD•Ï‰»‚ÌŒƒ‚µ‚¢—̈æ‚É‚¨‚¢‚Ä‚àŠ³ŽÒ‚ɍœK‚ȃPƒA‚ð’ñ‹Ÿ‚µ‚½‚¢Š´õÇê–åˆã•K{‚Ì1ûDƒrƒ‹EƒQƒCƒcŽ‚àu¢ŠE‚̉q¶Œüã‚É•K{‚̃KƒCƒhv‚Ə̎^‚µ‚½ƒƒNƒ`ƒ“‚ÆŠ´õÇ‚ÉŠÖ‚·‚éÅ‚àM—Š‚Å‚«‚郌ƒtƒ@ƒŒƒ“ƒX‚Å‚ ‚éD

Section 1: General aspects of vaccination
1. A short history of vaccination
2. Vaccine immunology
3. Correlates of protection
4. The vaccine industry
5. Vaccine manufacturing
6. Evolution of adjuvants across the centuries
7. Vaccine Additives and Manufacturing Residuals in Vaccines Licensed in the United States
8. Passive immunization
9. General immunization practices

Section 2: Licensed Vaccines and Vaccines in Development
10. Adenovirus vaccines
11. Anthrax vaccines
12. Biodefense and special pathogen vaccines
13. Cancer vaccines
14. Cholera vaccines
15. Combination vaccines
16. Cytomegalovirus vaccines
17. Dengue vaccines
18. Diarrhea caused by bacteria
19. Diphtheria toxoid
20. Ebola vaccines
21. Enterovirus 71
22. Epstein-Barr virus vaccines
23. Haemophilus influenzae type b vaccines
24. Hepatitis A vaccines
25. Hepatitis B vaccines
26. Hepatitis C vaccines
27. Hepatitis E vaccines
28. Herpes simplex virus vaccines
29. Human immunodeficiency virus vaccines
30. Human papillomavirus vaccines
31. Inactivated influenza vaccines
32. Influenza vaccine-live
33. Japanese encephalitis vaccines
34. Lyme disease vaccines
35. Malaria vaccines
36. Maternal immunization
37. Measles vaccine
38. Meningococcal Capsular A, C, W, and Y Conjugate Vaccines
39. Mumps vaccines
40. Noninfectious disease vaccines
41. Norovirus
42. Parasitic disease vaccines
43. Pertussis vaccines
44. Plague vaccines
45. Pneumococcal conjugate vaccine and pneumococcal common protein vaccines
46. Pneumococcal polysaccharide vaccines
47. Poliovirus vaccine-inactivated
48. Poliovirus vaccine-live
49. Rabies vaccines
50. Respiratory syncytial virus vaccines
51. Rotavirus vaccines
52. Rubella vaccine
53. Smallpox and vaccinia
54. Staphylococcus aureus vaccines
55. Streptococcus group A vaccines
56. Streptococcus group B vaccines
57. Tetanus toxoid
58. Tick-borne encephalitis virus vaccines
59. Tuberculosis vaccines
60. Typhoid fever vaccines
61. Varicella vaccine
62. Yellow fever vaccine
63. Zoster vaccine

Section 3: New Technologies
64. Technologies for making new vaccines
65. The development of gene-based vectors for immunization
66. Technologies to Improve Immunization

Section 4: Vaccination of special groups
67. Vaccination of immunocompromised hosts
68. Vaccination of human immunodeficiency virus-infected persons
69. Vaccines for international travel
70. Vaccines for health care personnel

Section 5: Public health and regulatory issues
71. Immunization in the United States
72. Immunization in Europe
73. Immunization in the Asia-Pacific region
74. Immunization in developing countries
75. Community Protection
76. Economic analyses of vaccine policies
77. Regulation and testing of vaccines
78. Regulation of vaccines in Europe
79. Regulation of vaccines in low and middle-income countries
80. Vaccine safety
81. Legal issues
82. Ethics

Appendix
Websites and Applications for Mobile Devices with Information about Immunization

‚±‚̏¤•i‚ðw“ü‚µ‚½•û‚É‚¨‚·‚·‚ß

Cellular & Molecular Immunology, 9th ed.
Cellular & Molecular Immunology, 9th ed.
Ú‚µ‚­Œ©‚é
Roitt's Essential Immunology, 13th ed.(Essentials Series)
Roitt's Essential Immunology, 13th ed.
(Essentials Series)
Ú‚µ‚­Œ©‚é